Globe Life (NYSE:GL) Announces FY 2027 Earnings Guidance

Globe Life (NYSE:GL) issued an update on its FY 2027 earnings guidance on Friday morning. The company provided earnings per share guidance of 16.100-17.100 for the period, compared to the consensus estimate of 16.510. Globe Life also updated its FY 2026 guidance to 15.350-15.650 EPS.

Globe Life Price Performance

NYSE:GL traded down $10.35 during trading hours on Friday, reaching $158.06. The company had a trading volume of 305,832 shares, compared to its average volume of 541,981. The stock has a 50-day moving average of $170.48 and a two-hundred day moving average of $167.25. Globe Life has a one year low of $127.85 and a one year high of $191.55. The firm has a market capitalization of $12.15 billion, a PE ratio of 10.50 and a beta of 0.44. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.43.

Globe Life (NYSE:GL) last released its quarterly earnings data on Wednesday, October 21st. The company reported $4.84 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.90 by ($0.06). The company had revenue of $1.60 billion for the quarter, compared to analyst estimates of $1.56 billion. Globe Life had a return on equity of 19.95% and a net margin of 18.89%. The business’s revenue was up 5.5% compared to the same quarter last year. During the same quarter in the prior year, the company earned $4.81 earnings per share. Analysts forecast that Globe Life will post 15.70 earnings per share for the current year.

Globe Life Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Investors of record on Monday, October 5th will be given a dividend of $0.33 per share. The ex-dividend date is Monday, October 5th. This represents a $1.32 dividend on an annualized basis and a dividend yield of 0.8%. Globe Life’s dividend payout ratio (DPR) is 8.76%.

Globe Life announced that its Board of Directors has initiated a share repurchase program on Monday, August 10th that permits the company to repurchase $2.50 billion in outstanding shares. This buyback authorization permits the company to purchase up to 17.7% of its stock through open market purchases. Stock buyback programs are typically an indication that the company’s leadership believes its shares are undervalued.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on GL shares. Piper Sandler downgraded shares of Globe Life from an “overweight” rating to a “neutral” rating and set a $165.00 price target for the company. in a report on Friday. Weiss Ratings raised shares of Globe Life from a “buy (b-)” rating to a “buy (b)” rating in a research note on Wednesday. UBS Group set a $165.00 price objective on shares of Globe Life in a report on Friday. TD Cowen cut their target price on shares of Globe Life from $225.00 to $215.00 and set a “buy” rating for the company in a research note on Friday. Finally, JPMorgan Chase & Co. lifted their target price on shares of Globe Life from $193.00 to $195.00 and gave the company an “overweight” rating in a research note on Thursday, October 15th. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $182.60.

Insiders Place Their Bets

In related news, CFO Thomas Kalmbach sold 21,000 shares of Globe Life stock in a transaction dated Thursday, July 30th. The stock was sold at an average price of $180.06, for a total value of $3,781,260.00. Following the completion of the transaction, the chief financial officer directly owned 50,568 shares of the company’s stock, valued at $9,105,274.08. The trade was a 29.34% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP Michael Majors sold 37,000 shares of the company’s stock in a transaction dated Wednesday, July 29th. The stock was sold at an average price of $178.64, for a total transaction of $6,609,680.00. Following the transaction, the executive vice president owned 53,518 shares in the company, valued at approximately $9,560,455.52. This trade represents a 40.88% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 143,650 shares of company stock worth $25,793,717 over the last ninety days. Company insiders own 2.11% of the company’s stock.

Globe Life News Summary

Here are the key news stories impacting Globe Life this week:

• Positive Sentiment: Globe Life reported third-quarter revenue of approximately $1.60 billion, above the $1.56 billion analyst consensus, with revenue up 5.5% year over year. Operating EPS increased to $4.84 from $4.81 a year earlier. Globe Life third-quarter 2026 results
• Positive Sentiment: Management is targeting $850 million to $950 million in parent excess cash flow for 2027, which could support capital returns, debt reduction or other shareholder-friendly actions. The company projects 2027 EPS of $16.10 to $17.10, a range that includes the $16.51 consensus estimate. Globe Life 2027 outlook
• Neutral Sentiment: The company’s 2027 EPS guidance of $16.10 to $17.10 implies continued earnings growth, but the broad range suggests uncertainty around operating performance and future underwriting results.
• Negative Sentiment: Third-quarter operating EPS of $4.84 missed estimates ranging from $4.87 to $4.90. Weaker underwriting income and higher expenses offset gains from increased premiums and investment income. Globe Life Q3 earnings miss
• Negative Sentiment: Globe Life cut its FY 2026 EPS outlook to $15.35-$15.65, below the $15.72 consensus estimate. Reports also cited losses at Evry Health as a factor pressuring the full-year guidance. Evry Health losses and Globe Life guidance
• Negative Sentiment: The quarter included a reported underwriting loss of about $6.4 million, raising investor concerns about claims trends, expense control and the company’s ability to convert premium growth into profits. Globe Life underwriting loss analysis

About Globe Life

Globe Life Inc (NYSE: GL) is an insurance holding company that provides individual life and supplemental health insurance products through a network of wholly owned subsidiaries. Its offerings are designed primarily for middle-income households and include term and whole life insurance, mortgage protection coverage, accident and supplemental health insurance, Medicare supplement policies, and annuities.

The company markets its products through several distribution channels, including exclusive and independent agency networks, direct-to-consumer sales, and workplace or union-affiliated programs.